
UCB · UCB S.A.
290.20
EURUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
Euro54.97B
PE
29.10
EV/EBITDA
25.7
DIV Yield
0.4%
Payout Ratio
12%
MQV Rating
2Strong
As at 05/11/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- HALO 100
- HALO 50
- HALO All
- HALO Capital Efficiency
- HALO Earnings Momentum
- HALO GARP
- HALO Growth
- HALO Small
- HALO Value
- Near Resistance
- Near Resistance (Realtime)
- Recent Price upgrade
- Short Term Trend - Long
Key Fundamentals
EPS 3 yr Growth
271.80%
EBITDA Margin
23.20%
Operating Cashflow
€2,163m
Free Cash Flow Return
16.60%
ROIC
12.00%
Interest Coverage
14.00
Quick Ratio
1.00
Performance
52 weeks range
Low 197.45 - 289.5
Trade Value (12mth)
US$17,022,327.00
1 week
4.47%
1 month
38.67%
YTD
20.67%
1 year
24.55%
All time high
289.50
Additional Data
Shares Outstanding (Fully Diluted)
194m
HALO Sector
Healthcare
Next Company Report Date
25-Feb-27
Next Ex Dividend Date
04-May-26
Next Dividend Pay Date
06-May-26
Reporting Currency
EUR
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Very Strong
Event
Very Strong
Halo Model
Mqv
Strong
Garp
Very Strong
Mqv Small
Strong
Momentum
Price
Very Weak
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Neutral
Quality
Capital Efficiency
Very Strong
Balance Sheet
Strong
Valuation
News & Announcements
No announcements available.
Key Stakeholders
| Name | Title |
| Financière de Tubize SA | Public Company |
| UCB SA | Public Company |
| OrbiMed Advisors Private Equity | Subsidiary |
| Lord Abbett (Ireland) Ltd. | Private Company |